chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A 73-year-old female, long-term care resident at Health and Rehab under the care of Dr., was sent to the emergency room tonight by staff at the nursing home.  The patient has some baseline dementia and acutely confused on top of that, so history is sketchy from her.  She complains of some suprapubic and left lower quadrant abdominal pain.  I was initially called to admit the patient for what was felt to be a possible appendicitis, new onset atrial fibrillation, electrolyte disturbances.  I called and spoke with the nurse who cares for her at the nursing home.  The patient the previous night had prolonged vomiting for 4-5 hours,  then subsided during the day today.  A KUB was done at the nursin nursing home yesterday  morning, which the nurse said was read as unremarkable.  However, this evening vomiting  began again.  The patient then became slightly confused from her baseline, had elevated temperature 99.4, blood pressure 176/88, so they sent her to the emergency room.  On arrival to the ED, she was in atrial fibrillation with a rate in the 120-range and was given IV diltiazem.  Because of elevated white blood cell count and  possible appendicitis on CT, Invanz was ordered in the ED.  A CT angiogram of the abdomen  and pelvis was done that was fairly unremarkable, although VRad noted they could not  completely rule out appendicitis.  Of note, the patient was diagnosed with COVID on January 5th and started on dexamethasone 6 mg daily on January 6th, which she is still taking.  No chest x-ray has been done yet.  Her oxygen saturation is 98% on room air.   PT IS STILL AN INPATIENT IN THIS TIME.
feeling down; last night she was sweaty; drainage; coughing a little; feels like COVID/ it feels almost like she had COVID again; feels like COVID/ it feels almost like she had COVID again; flu-like symptoms/ felt like she had the flu; head feels crazy; not feeling good; Booster; This is a spontaneous report based on information received by Pfizer. A non-contactable consumer (patient) reported that an 84-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunisation, at the age of 84-years, , dose 3 via an unspecified route of administration on 12Oct2021 (batch/lot number: 301458A) as DOSE 3 (BOOSTER), SINGLE, first single dose and second single dose on unspecified date; influenza vaccine (FLU), via an unspecified route of administration on 15Oct2021 for immunization; ibandronate sodium (IBANDRONATE, tablet, strength: 150 mg), via an unspecified route of administration from 18Jun2021 to Jul2021, then (lot number: C2108087; expiration date: 31May2024) from Sep2021 and ongoing, at once a month for bone. Medical history included COVID since Jul2021. Concomitant medications included pelargonium sidoides (UMCKA COLD CARE) and multivitamins. On 08Nov2021, the patient experienced flu-like symptoms, not feeling good, head feels crazy, feels like COVID, drainage, coughing a little. The patient reported that she was not feeling good, felt like she had the flu. She also reported that took her Pfizer booster and then took flu shot, her head feels crazy, it feels almost like she had COVID again. She was still not feeling good, she was feeling down. She started the medication (ibandronate sodium) in Jun2021 and had COVID in Jul2021 so she didn't take it then (interruption of therapy), started again in Sep2021. She had had some drainage and coughing a little. Last night she was sweaty. Patient used cold and flu medicine to treat the adverse events. The action taken to the events for ibandronate sodium was dose not changed. Outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Got both shots and still got the shingles/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got both shots and still got the shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK receipt date: 19-MAR-2023 The case was received from the patient interactive digital media. The patient got both shots and still got the shingles.  The patient stated that they were on his/her left side. The patient could not wear a bra, still had to wear underwear. The patient stated that he/she hated having shingles. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
patient was given RECOMBIVAX HB that was recalled; Administration of improperly stored vaccine; This spontaneous report has been received from a nurse referring to a 9 weeks old patient of unknown gender. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.      On 23-OCT-2020, the patient was vaccinated with hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (lot #: T007984, expiration date not reported, but upon internal validation established as 01-NOV-2022; 0.5 ml) via unknown route for prophylaxis. The vaccine was incorrectly stored and administered to the patient before being recalled (recalled product administered and product storage error).
Patient was administered an expired moderna covid vaccine.  Expired 2/12/23 - Patient was called on 3/27/23 and they reported no s/s.
Patient had a rash on her arm several inches below the injection site. The rash was red and hard to the touch. Patient says she started experiencing the symptoms the evening (Monday, 9/7) of the shot, and it has been improving. Patient said no other changes in her life that could've caused the rash. Patient already reached out to her PCP on Wednesday (9/9) morning, and is waiting to hear back.
Headache; muscle aches in neck and shoulders; aches all over; This is a spontaneous report received from a contactable consumer. A 72-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19, Formulation: Solution for injection, Batch/Lot number was EL9265), via an unspecified route of administration, administered in Arm Right on 02Feb2021 13:00 at single dose for covid-19 immunization. Medical history included hypertension. Concomitant medication included losartan; atenolol taken for an unspecified indication, start and stop date were not reported.  The patient experienced headache on 02Feb2021 19:00, muscle aches in neck and shoulders on, aches all over. The outcome of events is not recovered.
Pain, swelling, redness on L upper arm around injection site encompassing entire bicep. Patient started on Cephalexin, and then Levaquin was added. Symptoms worsened and patient was seen in Emergency Department and received one dose of IV Vancomycin, and then sent home with a course of Clindamycin.  Cellulitis resolved after the ER antibiotic treatments.
was administer with a two days expired dose; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 3-Aug-2022 Reporter's comment: The pharmacist reported that a patient was administered with a two days expired dose of Bexsero. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Bexsero, which led to expired vaccine used.
Chills, low fever, join pains, muscle aches, fatigue, headaches, injection site pain, slight nausea
He died four years later and still complained with them; Got vx, three weeks later got a bad case, died four years later; This case was reported by a consumer via interactive digital media and described the occurrence of death in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, more than 2 years after receiving Shingles vaccine, the patient experienced death (serious criteria death and GSK medically significant) and shingles. On an unknown date, the outcome of the death was fatal and the outcome of the shingles was not recovered/not resolved. The reported cause of death was unknown cause of death.   It was unknown if the reporter considered the death and shingles to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by patient's friend. Age at vaccination was not reported. The patient received a dose of Shingles vaccine and three weeks later got a bad case of shingles. He died four years later and still complained with them. Follow-up would not be possible as no contact details provided.; Reported Cause(s) of Death: Unknown cause of death
Approximately , 11am started getting chills all over, temperature 101.6 around 1pm with headache. I would take Motrin/ Tylenol when I felt my fever go up . The fever, headache and chills lasted Friday ,Sat , Sunday. On 12/21/20 had no more fever, no headache or chills. I have a great appetite, have no other symptoms.
Headache; Muscle pain; Rash; arm pain; it's achy all over; Itching; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient received BNT162b2 (BNT162B2), on 20Jul2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: IBUPROFEN; TYLENOL. Vaccination history included: Covid-19 vaccine (Primary immunization series complete. MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (First BOOSTER, SINGLE, MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: HEADACHE (non-serious) with onset Jul2022, outcome "unknown"; PRURITUS (non-serious) with onset Jul2022, outcome "unknown", described as "Itching"; MYALGIA (non-serious) with onset Jul2022, outcome "unknown", described as "Muscle pain"; RASH (non-serious) with onset Jul2022, outcome "unknown"; PAIN IN EXTREMITY (non-serious) with onset Jul2022, outcome "unknown", described as "arm pain"; MYALGIA (non-serious) with onset Jul2022, outcome "unknown", described as "it's achy all over". The events "headache", "muscle pain", "rash", "arm pain", "it's achy all over" and "itching" required physician office visit. Therapeutic measures were taken as a result of headache, myalgia, rash, pain in extremity, myalgia, pruritus.  Additional information: Consumer stated that she went to doctor and she was told to hold. She was taking antihistamines, She was taking Tylenol, alternatively most with Ibuprofen, hydrocortisone cream, about the, Cold compressive." Consumer stated that no other medications administered just regular multi-vitamins and Tylenol and Ibuprofen." Consumer stated, that this was her second booster dose.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I was fully vaxxed, I started coughing am June 24, I was in bed for 3 days, no fever no runny nose, persistent cough and a really bad headache. After a week I could function, I went to urgent care on 27th and they did a rapid test for covid 19 came back negative. And I lost taste and smell on the  29th,
Syncope after getting out of bed the morning after injection. Sweating followed by chills and urge to void. Stable after an additional hour. First time ever reaction or event of this kind. No other signs or symptoms noted.
Information has been received form a human resources department employee concerning a male pt who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant vaccination at the same time included a dose of influenza virus vaccine. Subsequently, the pt reported getting sick and feeling bad. The patient felt so bad after the shots that he "went to bed". At the time of the report, the pt was back at work and was feeling better. A product quality complaint was not involved. The human resources department employee mentioned this pt was one of more than 25 pts who had similar experiences post vaccination with pneumococcal 23v polysaccharide. Followup information was received from the administering nurse. The nurse noted that this population was needy and that many of the pts had long histories of being incarcerated. According to the nurse, none of the patients were bed ridden. The nurse described the patients' reported experiences as "flu like symptoms". Subsequently, the patients all recovered an none of them required treatment. Additional information is not expected.
My head is in a fog, dizziness, tired, left arm is still sore, night sweats
Patient reported to immunizer that she did not like needles. Following her vaccine, the patient walked around the pharmacy shopping during wait time. Once at POS counter, she collapsed (did not hit head) ~5pm. Patient thought she half fell and half sat down. She sat on floor leaning against cupboard. She reported reduced vision and hearing. BP ~100/60mmHg at ~5:05pm. She was provided water and cool cloth. Friend was brought into store from parking lot to be with her as well. She reported vision improving and was able to go back into vaccination room to rest. She reported not eating much that day - patient was provided with Hershey candy bar and sucker. ~5:15pm her BP was 100/62 and she continued to feel better/improve. 5:35pm patient reported felt well enough to go home (with friend). Throughout event, patient declined call parents or anyone else.
Started having rash on dorsal aspect of right ankle on Sunday - thought at first was chemical reaction to shower cleaning spray, or possibly even poison ivy??  because similar, smaller lesion showed up on upper dorsolateral thigh. Small, raised pruritic bumps started showing up on medial left knee, followed by lower back and then spreading to entire abdomen and lower chest. EXTREMELY PRURITIC!!!
Shortly after I developed extreme fatigue, mild headache and some arm soreness.  The arm was so sore touching it was unbareable for the first couple days.  The fatigue was so bad it kept me from working for about 5 days.  It eased up during that time but was really bad on me and by the 6th day I felt a little better just hasnt fully been feeling myself since.
After the vaccine was administered the patient sat in the waiting room for less than 5 minutes and then felt a fast HR, she felt hot and was worried that she was going to faint. She also felt shaking in her hands and her arms felt heavy.   She came back to the nurse that had administered her vaccine at 1:10pm where her oxygen level was monitored and she was given a cold cloth and water to drink. This lasted for about 20 minutes. Her oxygen level was monitored (~97%), her BP was checked at 1:45pm and it was 125/90. Her hotness, elevated HR, and shakes went away. At 2:00pm her BP was checked again and it was 139/96 and then again at 2:05pm where it was 132/90.   The patient stated that she felt fine and normal by now and also said that she had a BP cuff at work and at home and said that she would monitor it. All 3 of 3 follow up options discussed with patient: virtual care, the CDC, and/or 911 depending on her condition. The patient left at 2:15pm and patient was called 1 hour later for follow up.  On the follow-up call the patient stated that she was feeling fine and that her BP was 126/90. She said she would continue to monitor her BP and follow-up with virtual health if it wasn't back to normal by tomorrow.
Pt recv vax on 11/16/98; on 11/17/98 pt exp hot, red vax site; tx=Ibuprofen, Benadryl & ice
Case number PHEH2014US024633, is an initial spontaneous report from a health care professional (medical assistant) received on 04 Nov 2014. This report refers to a 17-year-old male patient. Past medical history and concomitant medications were not reported. On 26 Oct 2016, he was vaccinated with intramuscular dose of MENVEO (batch number: M14068) that was at 20.11 F for 49 hours (did not freeze). No adverse event was reported following this medication error (incorrect storage of drug).
This is a spontaneous report from a contactable physician. A 64-year-old male patient received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) (PNEUMOCOCCAL 13-VALENT CONJUGATED VACCINE (DIPHTHERIA CRM197 PROTEIN, lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced allergies with pneumococcal vaccine, swelling and fever on an unspecified date. The outcome of the event was unknown. Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) has submitted the same report to the regulatory authorities. The following information on the batch number has been requested.
Swelling, redness at injection site. Subject received a DTAP vaccine the day after the vaccination the child developed redness, swelling, warmth and induration at injection site.  Maximal diameter of redness was 14.2cm, maximal diameter of swelling was 8.5cm. No treatment required, resolution of symptoms was seven days following vaccination.
This case was reported by a healthcare professional and described the occurrence of vomiting in a 2-month-old female subject who was vaccinated with PEDIARIX (GlaxoSmithKline), ROTARIX. Concurrent vaccination included ACTHIB (Sanofi Pasteur MSD) and PREVNAR 13 (Wyeth) both given on 22 November 2010. On 22 November 2010 at 14:10 the subject inadvertently received an expired 1st dose of PEDIARIX at 0.5 ml in the right thigh and an expired 1st dose of ROTARIX (unknown). Two days later, on 24 November 2010, the subject experienced vomiting which resolved the same day. The reporter felt that the vomiting was due to the ROTARIX. Attribution to PEDIARIX was not provided. Follow-up information was received on 03 January 2011. It was reported that the subject experienced vomiting on 23 November 2010 which resolved the same day. The event was considered possibly related to treatment with GlaxoSmithKline vaccine and it was noted that the event could have been the result of more than one vaccine given on the same day.
Got shot about 2:00 PM, left after 30 minutes.  While sleeping around 3:45 AM started getting chills, had muscle pain, joint pain, feeling unwell, injection site pain as well.  Injection site pain is untouchable right now.  No fever during the night, at 9:30 AM temp 99.6.  At 7:00 AM had strong urge to vomit, but did not.  Could not stand or walk to the bathroom or anything.  Now still feeling better, but still has the tiredness, no chills, has a slight headache.   Seems to be getting better in general.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Apr2021 as dose 1, single (Lot number: EWO171) and on 11May2021 as dose 2, single (Lot number: EWO182) at the age of 52 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 29Dec2021 as dose 3 (booster), single (Lot number: 013H2B) for covid-19 immunisation. The patient's relevant medical history included: "IBD" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing). Concomitant medication(s) included: HYOSCYAMINE; FAMOTIDINE. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19"; DISEASE RECURRENCE (medically significant) with onset 02Sep2022, outcome "not recovered", described as "Rebound-tested positive again 3 days after negative test and symptoms returned". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: COVID 19 Treatment; (30Aug2022) Negative, notes: Rebound-tested positive again 3 days after negative test and symptoms returned; (02Sep2022) Positive, notes: Rebound-tested positive again 3 days after negative test and symptoms returned. Therapeutic measures were taken as a result of vaccination failure, covid-19, disease recurrence. Clinical course: Patient received Other medication in 2 weeks and had no known allergies. Rebound-tested positive again 3 days after negative test and symptoms returned. Patient received Paxlovid for treatment of COVID-19 from 23Aug2022 to 27Aug2022.
Severe neck pain and lower back of the head pain that was debilitating. I could not move my head left or right without pain. I went to urgent care and told it was just muscle tension, but the pain was intense enough where I couldn?t go to work.  This was about 2 days after the first dose and lasted a few days before going away.   With the second dose I just received, it looks like my skin was scraped slightly. It burns.
Began feeling feverish around 8pm, read at 102, took continuous Tylenol and continued to have 102 fever until 3pm next day. The morning after the shot I had a red circle,  the arm was swollen and warm to the touch. It is still continued to be swollen and red at this time. The fever stayed down to about 101 until this morning, (12/13) where I got it down to 99. At this time it is actually treatable with Tylenol.
On Friday October 21, 2022, I had bloody diarrhea. I called my doctor and spoke to the triage nurse. I had three more episodes of bloody diarrhea that day. The blood was bright red, not dark. It was lighter the following day. I didn't have it Sunday or Monday but again on Tuesday, October 24th. I am scheduled for a colonoscopy on December 6, 2022. I also have a bit of an aching pain (pain scale 3-4) in my lower abdomen during an episode and lasts for about 12 hours. I have not been able to have any tests for this yet.